COMMUNIQUÉS West-GlobeNewswire

BioDelivery Sciences Announces Further Significant Expanded Preferred Coverage For BELBUCA®
01/11/2018
More than 100 million Covered Lives Now Have Preferred Access to BELBUCA RALEIGH, N.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage [...]
Equillium to Present at Investor Conferences in November 2018
01/11/2018
LA JOLLA, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory [...]
Verrica Pharmaceuticals Announces Participation in the Jefferies 2018 London Healthcare Conference
01/11/2018
WEST CHESTER, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]
OncoMed Announces Third Quarter 2018 Financial Results and Operational Highlights
01/11/2018
-Company continues enrollment in Phase 1b navicixizumab trial following encouraging single agent and interim combination results in ovarian cancer; -Prepares for presentation of etigilimab data at Society for [...]
Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway
01/11/2018
WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]
Fluidigm Announces Third Quarter 2018 Financial Results
01/11/2018
Total revenue increases 17 percent to $29.0 million Mass cytometry revenue growth of 50 percent Instrument revenue growth of 32 percent SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation [...]
Dova Pharmaceuticals to Announce Third Quarter 2018 Financial Results on November 8, 2018
01/11/2018
DURHAM, N.C., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) will host a conference call on Thursday, November 8, 2018 at 4:30 p.m. ET to discuss third quarter 2018 financial results and [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/11/2018
BOSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Teladoc Health Announces Third Quarter 2018 Financial Results
01/11/2018
Third quarter revenue grows 62 percent year over year to $111.0 million Total paid membership grows 18 percent year over year to 22.6 million Third quarter total visits grow 110 percent year over year to 641,000 [...]
Sol-Gel Technologies Announces an Additional Collaborative Agreement for a Generic Product Candidate with Perrigo
01/11/2018
NESS ZIONA, Israel, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
Corcept Therapeutics Announces Third Quarter 2018 Financial Results and Provides Corporate Update
01/11/2018
MENLO PARK, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic [...]
TESARO Announces Third-Quarter 2018 Operating Results
01/11/2018
ZEJULA® Q3 net sales totaled $63 million compared to $39 million for Q3 2017 Top-line results for PRIMA trial of ZEJULA monotherapy for first-line ovarian cancer patients regardless of BRCA mutation status anticipated [...]
Novavax Appoints Rachel King to Board of Directors
01/11/2018
GAITHERSBURG, Md., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced the appointment of Rachel King, Co-Founder and Chief Executive Officer of GlycoMimetics, Inc., to its Board of Directors [...]
IRIDEX Announces 2018 Third Quarter Financial Results and Raises Full Year 2018 Guidance
01/11/2018
MOUNTAIN VIEW, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended September 29, 2018. Third Quarter Highlights Cyclo [...]
Geron Corporation Reports Third Quarter 2018 Financial Results and Recent Company Events
01/11/2018
Imetelstat program transition proceeding, including plans to initiate Phase 3 portion of IMerge Abstracts for IMbark and IMerge accepted for oral presentation at American Society of Hematology Meeting (ASH) in December [...]
Conatus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Program Updates
01/11/2018
SAN DIEGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today [...]
Helius Medical Technologies to Present at the 12th Annual Canaccord Medical Technologies & Diagnostics Forum
01/11/2018
NEWTOWN, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that [...]
Portola Pharmaceuticals to Present New Interim Phase 2 Results for Cerdulatinib During an Oral Session at the 60th American Society of Hematology (ASH) Annual Meeting
01/11/2018
– Differentiated Syk/JAK Inhibitor Studied in Patients with Heavily Pre-Treated T-Cell Malignancies – – Also Accepted: Two Posters on Andexxa ® and an Oral Session on the Burden of Hospital Readmissions Due to Venous [...]
NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings
01/11/2018
Management to Host Conference Call Today at 4:30 p.m. ET AMES, Iowa, Nov. 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the third quarter 2018 [...]

Pages